Literature DB >> 19116942

Early insulin secretion failure leads to diabetes in Chinese subjects with impaired glucose regulation.

Lei Qian1, Lihong Xu, Xiao Wang, Xuelian Fu, Yanyun Gu, Fan Lin, Yongde Peng, Guo Li, Min Luo.   

Abstract

BACKGROUND: Both beta-cell dysfunction and decreased insulin sensitivity are involved in the pathogenesis of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG), while their relative contribution in the progression to type 2 diabetes still remains controversial. The aim of the present study is to clarify this process in Chinese subjects by using cross-sectional method.
METHODS: 2,975 Chinese subjects were classified into: normal glucose tolerance (NGT), impaired glucose regulations (IGR), and diabetes mellitus (DM) based on oral glucose tolerance test (OGTT). The IGR group was sub-classified as isolated IFG, isolated IGT and combined glucose intolerance (CGI). The DM group was sub-classified as normal fasting plasma glucose and 2-hour hyperglycemia (N0D2), fasting hyperglycemia and normal 2-hour plasma glucose (D0N2), and both fasting and 2-hour hyperglycemia (D0D2).
RESULTS: As far as insulinogenic index (IGI) was concerned, there was no difference between IFG and IGT in either gender, however, HOMA2-B% (homeostasis model assessment for beta-cell function) of IGT was higher than that of IFG and CGI in both male and female (P < 0.05). In the diabetic sub-groups, IGI of N0D2 was higher than that of D0N2, and both deteriorated compared with those of IGT and IFG, respectively. HOMA2-B% of N0D2 was still higher than that of D0N2 and D0D2. No significant difference was detected in OGIS and HOMA2-S% (homeostasis model assessment for insulin sensitivity) between IFG and IGT, and this was the case between N0D2 and D0N2. OGIS and HOMA-IR of IGR sub-groups were not different from those of their diabetic counterparts.
CONCLUSION: Failure of beta-cell function might be the main reason for both IGT and IFG developing into diabetes instead of aggravated insulin resistance. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19116942     DOI: 10.1002/dmrr.922

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  26 in total

1.  Mysteries of type 2 diabetes: the Indian Elephant meets the Chinese Dragon.

Authors:  E C Rhodes; U P Gujral; K M Narayan
Journal:  Eur J Clin Nutr       Date:  2017-06-14       Impact factor: 4.016

2.  Novel views on new-onset diabetes after transplantation: development, prevention and treatment.

Authors:  Manfred Hecking; Johannes Werzowa; Michael Haidinger; Walter H Hörl; Julio Pascual; Klemens Budde; Fu L Luan; Akinlolu Ojo; Aiko P J de Vries; Esteban Porrini; Giovanni Pacini; Friedrich K Port; Adnan Sharif; Marcus D Säemann
Journal:  Nephrol Dial Transplant       Date:  2013-01-17       Impact factor: 5.992

Review 3.  Factors Related to the Glucose-Lowering Efficacy of Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Meta-Analysis Focusing on Ethnicity and Study Regions.

Authors:  Kayo Fujita; Masayuki Kaneko; Mamoru Narukawa
Journal:  Clin Drug Investig       Date:  2017-03       Impact factor: 2.859

4.  High dosage of Exendin-4 increased early insulin secretion in differentiated beta cells from mouse embryonic stem cells.

Authors:  Hua Li; Amy Lam; Ai-min Xu; Karen Sl Lam; Sookja Kim Chung
Journal:  Acta Pharmacol Sin       Date:  2010-04-26       Impact factor: 6.150

5.  Changes in Direct Medical Cost and Medications for Managing Diabetes in Beijing, China, 2016 to 2018: Electronic Insurance Data Analysis.

Authors:  Lixin Guo; Jie Zheng; Qi Pan; Qun Zhang; Yan Zhou; Weihao Wang; Lina Zhang; Solomon Tesfaye; Jie Zhang
Journal:  Ann Fam Med       Date:  2021 Jul-Aug       Impact factor: 5.166

6.  Comparison of the contributions of impaired beta cell function and insulin resistance to the development of type 2 diabetes in a Japanese community: the Hisayama Study.

Authors:  Masahito Yoshinari; Yoichiro Hirakawa; Jun Hata; Mayu Higashioka; Takanori Honda; Daigo Yoshida; Naoko Mukai; Udai Nakamura; Takanari Kitazono; Toshiharu Ninomiya
Journal:  Diabetologia       Date:  2021-04-28       Impact factor: 10.122

7.  Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and β-cell function in subjects with long-term remission.

Authors:  Yun Hu; Lirong Li; Yu Xu; Tingting Yu; Guoyu Tong; Hong Huang; Yan Bi; Jianping Weng; Dalong Zhu
Journal:  Diabetes Care       Date:  2011-06-16       Impact factor: 19.112

8.  Clinical characteristics and beta cell function in Chinese patients with newly diagnosed type 2 diabetes mellitus with different levels of serum triglyceride.

Authors:  Shuang Zheng; Huan Zhou; Tingting Han; Yangxue Li; Yao Zhang; Wei Liu; Yaomin Hu
Journal:  BMC Endocr Disord       Date:  2015-04-29       Impact factor: 2.763

9.  β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians.

Authors:  Daisuke Yabe; Yutaka Seino; Mitsuo Fukushima; Susumu Seino
Journal:  Curr Diab Rep       Date:  2015-06       Impact factor: 4.810

10.  Impact of triglycerides and waist circumference on insulin resistance and β-cell function in non-diabetic first-degree relatives of type 2 diabetes.

Authors:  Fahd Ahmed; Molham Al-Habori; Ebtesam Al-Zabedi; Riyadh Saif-Ali
Journal:  BMC Endocr Disord       Date:  2021-06-16       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.